REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
13.62
-0.14 (-1.02%)
At close: Jan 16, 2026, 4:00 PM EST
13.70
+0.08 (0.59%)
After-hours: Jan 16, 2026, 7:47 PM EST
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $689.49 million as of January 16, 2026. Its market cap has increased by 80.02% in one year.
Market Cap
689.49M
Enterprise Value
655.58M
1-Year Change
80.02%
Ranking
Category
Stock Price
$13.62
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $689.49M, a decrease of -7.98%. That is a compound annual growth rate of -0.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 689.50M | -5.42% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |